Metabolism of Trimethoprim in Man and Measurement of a New Metabolite: A New Fluorescence Assay
Urinary concentrations of trimethoprim (TMP) and its metabolites were measured in eight healthy subjects after oral administration of 160 mg of TMP in two tablets of Septra® (trimethoprim-sulfamethoxazole). Improved procedures for extraction of polar metabolites and for enzymic cleavage of conjugate...
Saved in:
Published in: | The Journal of infectious diseases Vol. 128; no. Supplement-3; pp. S580 - S583 |
---|---|
Main Authors: | , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
The University of Chicago Press
01-11-1973
University of Chicago Press |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Urinary concentrations of trimethoprim (TMP) and its metabolites were measured in eight healthy subjects after oral administration of 160 mg of TMP in two tablets of Septra® (trimethoprim-sulfamethoxazole). Improved procedures for extraction of polar metabolites and for enzymic cleavage of conjugated products were applied. The 1-oxide and conjugates of demethylated metabolites were found in substantially higher concentrations than those previously reported. A new metabolite, the 3-oxide of TMP, was identified, and urinary levels of this product were also measured. |
---|---|
Bibliography: | istex:FBAB7F8593A6239209587E05F45FE5AB88112750 Please address requests for reprints to Dr. Carl W. Sigel, Wellcome Research Laboratories, Burroughs Wellcome Company, Research Triangle Park, N.C. 27709. ark:/67375/HXZ-7TPJZL2T-T ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0022-1899 1537-6613 |
DOI: | 10.1093/infdis/128.Supplement_3.S580 |